|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Jan―17 |
Vitamin D status during the COVID-19 pandemic: a pragmatic approach to measurement and supplementation |
Giuseppe Lippi, Camilla Mattiuzzi |
2 |
[GO] |
2023―Oct―30 |
Impact of COVID-19 pandemic on serum 25-hydroxyvitamin D levels in Brazilian patients |
Gabriel Pissolati M. Bretz, João Rodrigo Campos, Adriano Alonso Veloso, Karina Braga Gomes, Adriano Basques Fernandes |
3 |
[GO] |
2023―Oct―30 |
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine |
Laura Pighi, Brandon M. Henry, Gian Luca Salvagno, Giuseppe Lippi |
4 |
[GO] |
2023―Jul―28 |
COVID-19: the global health emergency is over for the WHO, but not yet for laboratory medicine |
Giuseppe Lippi, Mario Plebani |
5 |
[GO] |
2023―Jan―05 |
Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections |
Eloísa Urrechaga, Pedro Pablo España, Ane Uranga, Mónica Fernández, Rana Zeeshan Haider, Luis Garcia de Guadiana, Urko Aguirre |
6 |
[GO] |
2023―Jan―04 |
Nationwide analysis of COVID-19 death rate throughout the pandemic in Italy |
Camilla Mattiuzzi, Giuseppe Lippi |
7 |
[GO] |
2022―Oct―26 |
COVID-19 diagnostics and early phase clinical trials: challenges and risk mitigation in the Omicron variants era |
Brandon Michael Henry, Giuseppe Lippi |
8 |
[GO] |
2022―Aug―29 |
Comparison of SARS-CoV-2 anti-spike IgG and anti-nucleoprotein IgG seroprevalence amongst a pre-vaccine cohort of healthcare workers at an academic medical center in Boston, Massachusetts |
Manisha Cole, Maura C. Dodge, Elizabeth R. Duffy, Jordyn N. Osterland, Susan H. Gawel, Lei Ye, Kyle de la Cena, Elizabeth J. Ragan, Sarah E. Weber, Elissa M. Schechter-Perkins, Tara C. Bouton, Karen R. Jacobson, Chris Andry, Yachana Kataria |
9 |
[GO] |
2022―Jul―19 |
COVID-19 vaccination in patients taking immunosuppressant drugs: what is the best strategy for improving immunogenicity? |
Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry |
10 |
[GO] |
2022―Jun―16 |
Is cellular immunity the future key for deciphering and monitoring COVID-19 vaccines efficacy? |
Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry |
11 |
[GO] |
2022―Mar―31 |
The landscape of SARS-CoV-2 genomic mutations |
Giuseppe Lippi, Brandon M. Henry |
12 |
[GO] |
2021―Sep―01 |
Specific leukocyte differential and morphological alarms a clue for the detection of SARS-CoV-2 infection |
Eloísa Urrechaga, Oihane Bóveda, Milagros Hernández, Blanca García San Vicente, Mónica Fernández, Helena Redín, Irene Pérez, Cristian Morales-Indiano, María José Alcaide, Luís García de Guadiana |
13 |
[GO] |
2021―Jun―16 |
Comparing the performance of two commercial assays for detection of SARS-CoV-2 in samples with low viral load |
Kok-Siong Poon, Nancy Wen-Sim Tee |
14 |
[GO] |
2021―May―13 |
Emerging COVID-19 diagnostics in context-what about testing saliva? |
Kok-Siong Poon, Nancy Wen-Sim Tee |
15 |
[GO] |
2021―May―13 |
Potential drawbacks of pharmacy-based COVID-19 testing |
Giuseppe Lippi, Brandon Michael Henry, Mario Plebani |
16 |
[GO] |
2021―Jan―31 |
Altered lipid profile in patients with COVID-19 infection |
Vincenzo Roccaforte, Massimo Daves, Giuseppe Lippi, Marta Spreafico, Claudio Bonato |
17 |
[GO] |
2021―Jan―31 |
The real origin of SARS-CoV-2: does it really matter? |
Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar |
18 |
[GO] |
2020―Oct―22 |
Assessment of immune response against SARS-CoV-2 at emergency department evaluation in COVID-19 patients |
Justin L. Benoit, Stefanie W. Benoit, James Rose, Jonathan Hoehn, Giuseppe Lippi, Brandon Michael Henry |
19 |
[GO] |
2020―Oct―22 |
Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi |
Steven Munharo, Symon Nayupe, Patrick Mbulaje, Parth Patel, Confidence Banda, Kristine Joy Abordo Gacutno, Xu Lin, Isaac Thom Shawa, Don Eliseo Lucero-Prisno 3rd |